LBA21_PRProspective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy)
Grothey, A., Sobrero, A., Meyerhardt, J.A., Yoshino, T., Paul, J., Taieb, J., Souglakos, I., Kerr, R., Labianca, R., Shields, A.F., Bonnetain, F., Yamanaka, T., Boukovinas, I., Shi, Q., Meyers, J.P.,Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.014
Date:
September, 2017
File:
PDF, 71 KB
english, 2017